Centre is partner in Covaxin's manufacturing so they can share formula with others: Satyendar Jain
Amid a shortage of COVID-19 vaccine in the national capital, Delhi Health Minister Satyendar Jain on Friday said that the Central government is a partner in Covaxin's manufacturing and hence it can share the formula with others.
He said that Delhi, on Thursday, reported 10,489 positive cases and the positivity rate was 14.24 percent. The highest positivity rate was 36 percent in Delhi so now it is less than half of it, he said.
Also Read | Coronavirus India: PM Narendra Modi a ‘super-spreader’ of COVID-19, says IMA Vice President
"We're seeing a decline in trends from April 24," Delhi Health Minister Satyendar Jain said.
Meanwhile, he said that Covaxin (COVID-19 vaccine) stock has almost ended in Delhi. "We only have 2-3 days of stock for Covidshield vaccines for 18- 44 years of age group," he added.
Also Read | Coronavirus: Delhi witnesses major decline in COVID-19 cases in 24 hours
Furthermore, he said that "We can't mix already assigned centers for Covaxin and Covishield vaccines."
Through the global tender, we can only procure Covishield, Covaxin, and Sputnik V in the country, he said. Adding, he said that "If there was a need for a global tender then it should be done by the Central government."
The Central government is a partner in COVID-19 vaccine Covaxin's manufacturing so they can share the formula with others, he said, adding that the Centre should cap prices of all vaccines and it should not be more than Rs 150 per dose.
"We'll start vaccination for 45 years and above age group in government schools soon," he added.
Click here to follow PTC News on Twitter
-PTC News
